Literature DB >> 26801671

Low p21 level is necessary for the suppressive effects of micoRNA-31 on glioma cell migration and invasion.

Jun Pan1,2,3, Fengfei Lu1,2,3, Hongchao Xu1,2,3, Qifu Wang1,2,3, Chunnan Lin1,2,3, Shizhong Zhang4,5,6.   

Abstract

MicroRNAs (miRNAs), a kind of endogenous non-coding RNAs, regulate gene expression through binding to the 3'-untranslational region (UTR) of target messenger RNAs (mRNAs) and act as endogenous agents of RNA interference, resulting in either mRNA degradation or translational repression. MiR-31 has been demonstrated to be associated with the development and progression of glioma. However, the underlying molecular mechanism remains largely unclear. In the present study, we demonstrated that miR-31 only inhibited the cell migration and invasion, as well as the expression of a known miR-31 target oncogene radixin, in U251 glioma cells that expressed low level of p21; however, miR-31 showed no above effects on glioma SHG44 cells that highly expressed p21. Moreover, upregulation of p21 in U251 cells reversed the suppressive effects of miR-31 on the cell migration and invasion, suggesting that low p21 level is necessary for the miR-31-mediated inhibitory effects on glioma. Furthermore, analysis for 35 glioma specimens showed that the expression of radixin was negatively correlated with the miR-31 level in glioma tissues with low p21 expression; however, no such correlation was found in glioma tissues with high p21 level, further supporting that the low p21 level is necessary for the suppressive effect of miR-31 on the expression of its target oncogenes. In summary, our study demonstrates that the suppressive effect of miR-31 on glioma cell migration and invasion is p21-dependent, and suggests that miR-31 may be used for the treatment of patients with p21-deficent glioma.

Entities:  

Keywords:  Glioma; Invasion; MicroRNA-31; Migration; p21

Mesh:

Substances:

Year:  2016        PMID: 26801671     DOI: 10.1007/s13277-016-4788-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  30 in total

Review 1.  Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis.

Authors:  Vivian F Zhu; Jingxuan Yang; Drake G Lebrun; Min Li
Journal:  Cancer Lett       Date:  2011-11-07       Impact factor: 8.679

2.  Human miR-31 targets radixin and inhibits migration and invasion of glioma cells.

Authors:  Dasong Hua; Dong Ding; Xu Han; Weiyi Zhang; Na Zhao; Gregory Foltz; Qing Lan; Qiang Huang; Biaoyang Lin
Journal:  Oncol Rep       Date:  2011-11-15       Impact factor: 3.906

3.  Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers.

Authors:  Chad J Creighton; Michael D Fountain; Zhifeng Yu; Ankur K Nagaraja; Huifeng Zhu; Mahjabeen Khan; Emuejevoke Olokpa; Azam Zariff; Preethi H Gunaratne; Martin M Matzuk; Matthew L Anderson
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

4.  miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma.

Authors:  Chung-Ji Liu; Meng-Miao Tsai; Pei-Shih Hung; Shou-Yen Kao; Tsung-Yun Liu; Kou-Juey Wu; Shih-Hwa Chiou; Shu-Chun Lin; Kuo-Wei Chang
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

5.  Suppression of centrosome protein TACC3 induces G1 arrest and cell death through activation of p38-p53-p21 stress signaling pathway.

Authors:  Thazhath V Suhail; Puja Singh; Tapas K Manna
Journal:  Eur J Cell Biol       Date:  2015-01-05       Impact factor: 4.492

6.  Meta-analysis of microRNA expression in lung cancer.

Authors:  Urmo Võsa; Tõnu Vooder; Raivo Kolde; Jaak Vilo; Andres Metspalu; Tarmo Annilo
Journal:  Int J Cancer       Date:  2012-12-27       Impact factor: 7.396

7.  Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas.

Authors:  Shuai Wang; Baohua Jiao; Shaomei Geng; Jian Song; Zhaohui Liang; Shengkui Lu
Journal:  J Neurol Sci       Date:  2013-12-15       Impact factor: 3.181

8.  Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues.

Authors:  Junming Guo; Ying Miao; Bingxiu Xiao; Rong Huan; Zhen Jiang; Dan Meng; Yanjun Wang
Journal:  J Gastroenterol Hepatol       Date:  2008-11-03       Impact factor: 4.029

9.  MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9.

Authors:  Zhuo Dong; Zhiwei Zhong; Lihua Yang; Shaomin Wang; Zhaohui Gong
Journal:  Cancer Lett       Date:  2013-10-04       Impact factor: 8.679

Review 10.  p21(WAF1/CIP1) and cancer: a shifting paradigm?

Authors:  Andrei L Gartel
Journal:  Biofactors       Date:  2009 Mar-Apr       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.